Axsome Therapeutics Stock Price - AXSM

0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Axsome Therapeutics Inc AXSM NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-1.46 -1.58% 91.13 90.00 92.39 92.00 92.59 20:00:00
Bid Price Ask Price Spread Spread % News
90.00 93.50 3.50 3.74% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,688 440,350 $ 91.22 $ 40,166,843 658,496 7.64 - 121.06
Last Trade Time Type Quantity Stock Price Currency
17:30:49 2 $ 91.13 USD

Axsome Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.37B 37.02M $ -30.97M -1.14 - 36.23M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Axsome Therapeutics News

Loading Messages....

Latest AXSM Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AXSM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week89.1295.4488.6091.88592,4432.012.26%
1 Month87.7898.4780.0690.91591,7883.353.82%
3 Months38.97121.0637.5182.011,271,09552.16133.85%
6 Months25.12121.0613.6455.131,064,23466.01262.78%
1 Year8.77121.067.6436.481,120,96582.36939.11%
3 Years4.30121.061.9422.87675,86486.832,019.3%
5 Years9.00121.061.9422.55488,03282.13912.56%

Axsome Therapeutics Description

Axsome Therapeutics Inc is a United States-based healthcare service provider. As a pre-clinical therapeutics developer, the company attends primarily to central nervous system disorders such as Alzheimer's. Its product portfolio consists of novel drugs like the AXS-02 (disodium zoledronate tetrahydrate), which is an oral, non-opioid therapeutic for chronic pain and the AXS-05, which is a fixed-dose combination of dextromethorphan and bupropion. The AXS-02 addresses pain in over three conditions, such as complex regional pain syndrome, knee osteoarthritis and chronic low back pain. The AXS-05 on the other hand, treats resistant depression and agitation in patients with Alzheimer's disease. Both the products have passed the preclinical, Phase 1 and Phase 2 stages of development.

Your Recent History
Axsome The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.